Browse Guides  internal medicine  renal medicine

Acute renal failure

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Prevention

Contrast medium nephrotoxicity

Give high-risk patients pre- and post-contrast 

  • 0.45% saline (1 mg/kg/hr for 12 hours) c
  • acetylcysteine 600 mg orally twice daily a

Why?

  • Patients with chronic renal insufficiency who received acetylcysteine and saline compared with placebo and saline are less likely to develop an acute reduction in renal function, and have a smaller change in serum creatinine levels (on average 50 µmol less). a

Acetylcysteine reduces worsening renal function following contrast media.

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
chronic renal insufficiency undergoing CT contrast study a acetylcysteine and saline infusion placebo and saline infusion acute reduction in renal function
at 2 days
21% 89%
(14% to 98%)
5
(3 to 18)

 


Expiry date: July 2003
Levels of Evidence used in grading these guides

Authors   C   Clase , CM   Ball
Reviewer   S   Hsu
CAT Writers   C   Clase , CM   Ball